Practice guideline for pharmacists: The management of late-onset hypogonadism

Introduction Late-onset hypogonadism (LOH), also known as testosterone deficiency (TD) syndrome, is a medical condition that affects middle-aged and older men due to a decline in testosterone levels as they age. The European Male Aging Study reported a 0.4% annual decline in total testosterone and a 1.3% annual decline in free testosterone in its cohort of men aged 40 to 79 years. LOH is characterized by the presence of indicative signs and symptoms and a decrease in serum testosterone levels either due to testicular defects or defects of the hypothalamicpituitary-gonadal (HPG) axis. A large, long-term study conducted in the United Kingdom and the United States showed that up to 40% of men were obtaining testosterone without documented TD. Other studies have shown that there is a high prevalence of underdiagnosis of TD. Because of these discrepancies, it is important that practitioners be prudent in their diagnosis and management of LOH.

• Publication year

  2021

• Venue

  Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

• Publication date

  2021-10-11

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1177/17151635211047468PMCID 8756369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians

  2020cited by this paper
• Implementation of a Pilot Pharmacist Testosterone Therapy Management Service

  2020cited by this paper
• European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males

  2020influential reference
• Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.

  2019cited by this paper
• Testosterone replacement therapy: For whom, when and how?

  2018cited by this paper
• Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

  2018influential reference
• Evaluation and Management of Testosterone Deficiency: AUA Guideline

  2018influential reference
• Clinical practice update on testosterone therapy for male hypogonadism: Contrasting perspectives to optimize care

  2018influential reference
• Alternatives to Testosterone Therapy: A Review.

  2018cited by this paper
• British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice.

  2017influential reference
• Testosterone Therapy: Review of Clinical Applications.

  2017cited by this paper
• Testosterone and Cardiovascular Disease.

  2016cited by this paper
• Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

  2016influential reference
• Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations

  2016influential reference
• Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men

  2015influential reference
• Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline

  2015cited by this paper
• The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men.

  2015influential reference
• Counseling Male Patients on Testosterone Replacement Therapy With Efficacy and Safety in Mind

  2015cited by this paper
• Male hypogonadism and testosterone replacement therapy

  2013cited by this paper
• Late-onset hypogonadism.

  2011cited by this paper
• AGREE II: advancing guideline development, reporting and evaluation in health care

  2010cited by this paper
• AGREE II: advancing guideline development, reporting, and evaluation in health care.

  2010cited by this paper
• ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males

  2009influential reference
• A Manual of 2008 ISA, ISSAM, EAU, EAA and ASA Recommendations: Investigation, Treatment and Monitoring of Late-onset Hypogonadism in Males.

  2009cited by this paper
• Clinical Practice Manual for Late‐onset Hypogonadism Syndrome

  2008influential reference

• How Low is Low Enough to be Given Testosterone Replacement Therapy in Patients with Late Onset Hypogonadism? What Should Be Evaluated? A Case Report

  2022cites this paper